Monday, November 01, 2021 10:24:14 AM
Recent ABVC News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/26/2024 08:30:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 09:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 08:05:34 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 07/12/2024 08:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 12:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:00:15 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/23/2024 08:30:39 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/22/2024 09:00:20 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/22/2024 06:31:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/17/2024 09:00:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/17/2024 08:01:51 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 01:27:45 PM
- AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share • GlobeNewswire Inc. • 04/18/2024 01:25:00 PM
- ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M • GlobeNewswire Inc. • 04/17/2024 01:00:00 PM
- ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M • GlobeNewswire Inc. • 04/10/2024 12:30:00 PM
- ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M • GlobeNewswire Inc. • 03/26/2024 12:30:00 PM
- AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars • GlobeNewswire Inc. • 03/21/2024 12:30:00 PM
- ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine • GlobeNewswire Inc. • 03/19/2024 12:30:00 PM
- ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update • GlobeNewswire Inc. • 03/14/2024 01:30:31 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:32:35 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:31:06 PM
- ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars • GlobeNewswire Inc. • 02/27/2024 01:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/16/2024 10:04:42 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM